Biomerica (BMRA)
(Delayed Data from NSDQ)
$3.11 USD
-0.04 (-1.27%)
Updated Aug 7, 2025 03:59 PM ET
After-Market: $3.16 +0.05 (1.61%) 6:38 PM ET
NA Value
NA Growth NA Momentum NA VGMFundamental Charts
About Market Cap
As of the previous market close, Biomerica, Inc. has a market cap of $8.02M, which represents its share price of $3.15 multiplied by its outstanding shares number of 2.55M. As a small-cap company, BMRA's shareholders are generally exposed to more risk than shareholders of mid and large-cap companies.
The company's Market Capitalization is a measurement of company size. It is calculation of the company's share price times the number of outstanding shares. Large market cap companies give stability and are good long-term investments. Small market cap companies can produce faster growth and bigger returns, but their stockholders are exposed to more risk.
BMRA 3.11 -0.04(-1.27%)
Will BMRA be a Portfolio Killer in August?
Zacks Investment Research is releasing its prediction for BMRA based on the 1-3 month trading system that more than doubles the S&P 500.
Other News for BMRA
Biomerica announces inFoods IBS received CPT PLA code
Biomerica (BMRA) Appoints New Chief Commercial Officer | BMRA Stock News
Biomerica announces appointment of Madel as Chief Commercial Officer
Clinical Diagnostics Industry Leader Scott Madel Joins Biomerica's Team as Chief Commercial ...